Health Canada
- Status: approved
Nalbuphine in superficial cervical plexus block (Nalbuphine in superficial cervical plexus block) regulatory status in Canada.
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Yes. Health Canada has authorised it.
Kasr El Aini Hospital is the originator. The local marketing authorisation holder may differ — check the official source linked above.